Lindsten K - Search Results

1

GFP reporter mouse models of UPS proteolytic function.

Lindsten K, Menéndez-Benito V, Masucci MG, Dantuma NP, Kumarapeli AR, Horak KM, Zheng H, Wang X. Lindsten K, et al. FASEB J. 2006 May;20(7):1027; author reply 1027-8. doi: 10.1096/fj.06-0504ufm. FASEB J. 2006. PMID: 16675852 No abstract available.

2

A transgenic mouse model of the ubiquitin/proteasome system.

Lindsten K, Menéndez-Benito V, Masucci MG, Dantuma NP. Lindsten K, et al. Nat Biotechnol. 2003 Aug;21(8):897-902. doi: 10.1038/nbt851. Epub 2003 Jul 20. Nat Biotechnol. 2003. PMID: 12872133

3

Stressing the ubiquitin-proteasome system.

Dantuma NP, Lindsten K. Dantuma NP, et al. Among authors: lindsten k. Cardiovasc Res. 2010 Jan 15;85(2):263-71. doi: 10.1093/cvr/cvp255. Epub 2009 Jul 25. Cardiovasc Res. 2010. PMID: 19633314 Review.

4

Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation.

Lindsten K, de Vrij FM, Verhoef LG, Fischer DF, van Leeuwen FW, Hol EM, Masucci MG, Dantuma NP. Lindsten K, et al. J Cell Biol. 2002 Apr 29;157(3):417-27. doi: 10.1083/jcb.200111034. Epub 2002 Apr 29. J Cell Biol. 2002. PMID: 11980917 Free PMC article.

5

Monitoring the ubiquitin/proteasome system in conformational diseases.

Lindsten K, Dantuma NP. Lindsten K, et al. Ageing Res Rev. 2003 Oct;2(4):433-49. doi: 10.1016/s1568-1637(03)00031-x. Ageing Res Rev. 2003. PMID: 14522245 Review.

6

Aggregate formation inhibits proteasomal degradation of polyglutamine proteins.

Verhoef LG, Lindsten K, Masucci MG, Dantuma NP. Verhoef LG, et al. Among authors: lindsten k. Hum Mol Genet. 2002 Oct 15;11(22):2689-700. doi: 10.1093/hmg/11.22.2689. Hum Mol Genet. 2002. PMID: 12374759

7

Non-infectious fluorimetric assay for phenotyping of drug-resistant HIV proteinase mutants.

Majerová-Uhlíková T, Dantuma NP, Lindsten K, Masucci MG, Konvalinka J. Majerová-Uhlíková T, et al. Among authors: lindsten k. J Clin Virol. 2006 May;36(1):50-9. doi: 10.1016/j.jcv.2006.01.014. Epub 2006 Mar 9. J Clin Virol. 2006. PMID: 16527535

OBJECTIVE: We present a non-infectious cell-based assay for drug resistance quantification of HIV proteinase (PR) - an important target of HAART. STUDY DESIGN: Previously, we showed [Lindsten K, Uhlikova T, Konvalinka J, Masucci MG, Dantuma NP. Cell-based fluorescen …

OBJECTIVE: We present a non-infectious cell-based assay for drug resistance quantification of HIV proteinase (PR) - an important target of H …

8

Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells.

Dantuma NP, Lindsten K, Glas R, Jellne M, Masucci MG. Dantuma NP, et al. Among authors: lindsten k. Nat Biotechnol. 2000 May;18(5):538-43. doi: 10.1038/75406. Nat Biotechnol. 2000. PMID: 10802622

9

Inhibition of proteasomal degradation by the gly-Ala repeat of Epstein-Barr virus is influenced by the length of the repeat and the strength of the degradation signal.

Dantuma NP, Heessen S, Lindsten K, Jellne M, Masucci MG. Dantuma NP, et al. Among authors: lindsten k. Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8381-5. doi: 10.1073/pnas.140217397. Proc Natl Acad Sci U S A. 2000. PMID: 10890896 Free PMC article.

10

Cell-based fluorescence assay for human immunodeficiency virus type 1 protease activity.

Lindsten K, Uhlíková T, Konvalinka J, Masucci MG, Dantuma NP. Lindsten K, et al. Antimicrob Agents Chemother. 2001 Sep;45(9):2616-22. doi: 10.1128/AAC.45.9.2616-2622.2001. Antimicrob Agents Chemother. 2001. PMID: 11502538 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters